Concepedia

Augusto Valdivia

AV

2

Publications

52

Citations

2

H-Index

2022

Active since

Affiliations

Vall d'Hebron Institute of Oncology(Current)

Augusto Valdivia is an author at Vall d'Hebron Institute of Oncology specializing in obstetrics, tumor immunity, and cancer research.

ORCID

Top concepts

Publications per year

2022–2024

2

Publications

2

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

Joshua C. Horan, Anupong Tangpeerachaikul, Aurélie Swalduz et al. · Cancer Discovery · 2024 · 42 citations · Full text

Treatment strategies in cervical cancer: treatment of advanced disease

Augusto Valdivia, Juan Francisco Grau-Béjar, Carmen García-Durán et al. · Journal of Cancer Metastasis and Treatment · 2022 · 10 citations · Full text

, , +26

Rows per page

1–2 of 2